NorthWest Biotherapeutics Inc (NWBO)

[pqr]

I actually disagree a bit with Gary I think when the initial data became available the company issued an overly optimistic prediction of the completion of the anticipated analysis. Thereafter a significant and unanticipated publication opportunity arose and the planned PR schedule was delayed by that work. But for reasons many have discussed the company did not feel it appropriate/a best practice to PR that change in its disclosure schedule. GLTAL and patients.